Adagio Medical (ADGM) versus Its Rivals Critical Contrast

Adagio Medical (NASDAQ:ADGM) is one of 142 public companies in the “MED INSTRUMENTS” industry, but how does it weigh in compared to its competitors? We will compare Adagio Medical to related companies based on the strength of its institutional ownership, earnings, analyst recommendations, risk, valuation, dividends and profitability.

Volatility & Risk

Adagio Medical has a beta of 0.14, suggesting that its stock price is 86% less volatile than the S&P 500. Comparatively, Adagio Medical’s competitors have a beta of 1.88, suggesting that their average stock price is 88% more volatile than the S&P 500.

Valuation & Earnings

This table compares Adagio Medical and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Adagio Medical	$266,000.00	-$75.04 million	-0.53
Adagio Medical Competitors	$1.75 billion	$196.07 million	5.25

Adagio Medical’s competitors have higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Adagio Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-791.01%	-199.58%
Adagio Medical Competitors	-482.31%	-113.49%	-21.33%

Insider & Institutional Ownership

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 54.1% of shares of all “MED INSTRUMENTS” companies are held by institutional investors. 5.2% of Adagio Medical shares are held by company insiders. Comparatively, 14.1% of shares of all “MED INSTRUMENTS” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Adagio Medical and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1	0	0	0	1.00
Adagio Medical Competitors	1229	3827	7161	271	2.52

As a group, “MED INSTRUMENTS” companies have a potential upside of 9.35%. Given Adagio Medical’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical has less favorable growth aspects than its competitors.

Summary

Adagio Medical competitors beat Adagio Medical on 12 of the 13 factors compared.

Adagio Medical Company Profile

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.